Cartalax
Khavinson tripeptide bioregulator studied in connective-tissue and fibroblast aging models.
Available sizes
| SKU | Per vial | Pack | |
|---|---|---|---|
| LAX20 | 20 mg | 10 vials / box |
Order Cartalax
Pricing is quoted directly and is competitive at every tier — message us with the SKUs you want and quantities for a quote.
Replies within 36 hours. Cryptocurrency (preferred) or card / money-app with a processing fee. COA for this batch available on request.
Cartalax is the synthetic tripeptide Ala-Glu-Asp (AED), developed from cartilage peptide fractions in the Khavinson bioregulator series.
In vitro, AED and related short peptides modulated skin-fibroblast function during replicative aging 1 and regulated gene expression in aging mesenchymal stem-cell cultures 2.
At a glance
- Connective-tissue tripeptide bioregulator
- 20 mg vials
- Form
- Lyophilized powder
- Purity
- HPLC-verified — Certificate of Analysis available on request
- Pack size
- Box of 10 vials
- Storage
- Lyophilized: −20 °C, protected from light (2–8 °C short-term). Reconstituted: 2–8 °C.
- Sequence
- Ala-Glu-Asp
- Formula
- C12H19N3O8
- Mol. weight
- 333.3 g/mol
Sequence, formula and CAS data are provided for identification. Batch-specific purity, mass-spec and HPLC data are on the Certificate of Analysis — ask for it with your order.
- Lin'kova NS, Drobintseva AO, Orlova OA, et al. Peptide Regulation of Skin Fibroblast Functions during Their Aging In Vitro. Bull Exp Biol Med. 2016;161(1):175-8.
- Ashapkin V, Khavinson V, Shilovsky G, et al. Gene expression in human mesenchymal stem cell aging cultures: modulation by short peptides. Mol Biol Rep. 2020;47(6):4323-4329.
Citations retrieved from PubMed (NCBI). Links open the publisher record via DOI and the PubMed abstract.